Considering the relatively short hospitalization time prior to death of our COVID-19 cohort (14.5 days), and the similar immunoreactivity pattern compared to other available studies, it could be inferred that TMEM119 downregulation does not occur early in COVID-19. Here, TMEM119 is linked to COVID-19.